Exenatide: a guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus

Author： Adis International Limited

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.10, 2007-10, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)

By Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 935-954

Adis International

Access to resources Recommend Favorite

Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

By Scott Lesley J.

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1679-1707

Adis International

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert Hagan Michael A.

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Sitagliptin/metformin fixed-dose combination: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Liraglutide: a guide to its use in type 2 diabetes mellitus

Drugs & Therapy Perspectives, Vol. 26, Iss. 9, 2010-09 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite